2013 American Transplant Congress
Downregulation of Complement Activity Via the Mannan-Binding Lectin (MBL) Pathway by Dietary Restriction and Fasting
BackgroundSeventy-two hours of preoperative fasting (F) or 2 weeks of 30% dietary restriction (DR) offers robust protection against renal ischemia-reperfusion injury (IRI) in mice. However,…2013 American Transplant Congress
Impact of Tacrolimus (FK) Level on Evolution of Graft Function in the First Year after Kidney Transplant (KT) among Recipients with DGF: A Ten Year Retrospective Analysis
Univ of Florida, Gainesville, FL
Purpose: We aimed to analyze the impact of FK levels at selected time points after KT on the evolution of graft function (based on estimated…2013 American Transplant Congress
Donor-Specific HLA Antibodies: Prediction of Pancreas Graft Outcome
Oxford Transplant Centre, Oxford, United Kingdom
Donor-specific HLA antibodies (DSA) are associated with poorer outcomes in kidney transplantation, however the role of DSA in pancreas transplantation is less well known. This…2013 American Transplant Congress
Does Mannose-Binding Lectin Plasma Level Predict the Incidence of Cytomegalovirus Disease in Solid-Organ Transplant Recipients?
CHUV, Lausanne; , Basel; , Zuerich; , Bern; , Geneva; , St Gallen, Switzerland
Background: Mannose-binding lectin (MBL) is the initial component of the third complement activation pathway. Genetically-determined deficiency which is very prevalent has been implicated in the…2013 American Transplant Congress
Growth Differentiation Factor 15 (GDF-15) Is Related to Anemia and Iron Metabolism in Heart Allograft Recipients
Anemia is more prevalent in heartl transplant recipients than in GFR-matched CKD patients, due to the combination of additional factors. Growth differentiation factor 15 (GDF-15)…2013 American Transplant Congress
Comparison of Patient and Graft Outcomes of HUS Kidney Transplants (KT) with and without Post Transplant Recurrence: A 10 Year Retrospective Analysis
Univ of Florida, Gainesville, FL
Purpose: Our study aimed to determine the difference in patient and graft outcomes between HUS Kidney Transplant Recipients (HUSKTR) with and without disease recurrence after…2013 American Transplant Congress
Cardiac Improvement Is Even Better in Diabetic End-Stage Renal Patients after Kidney Transplantation
Transplant Center, Acibadem University, Istanbul, Turkey
Cardiac disorders are very common in individuals with chronic kidney disease and are associated with high morbidity and mortality. The purpose of this study was…2013 American Transplant Congress
You Are What You Eat: Impact of Early Metabolic Syndrome on Long-Term Outcome after Heart Transplantation
BackroundMetabolic syndrome (MS) is seen in a high rate of heart transplant patients. In recent studies MS has been associated with long-term complications. The aim…2013 American Transplant Congress
T Cell Help Is Critical in Determining Mode of Alloantibody-Mediated Allograft Rejection
Department of Surgery, University of Cambridge, Cambridge, United Kingdom
INTRODUCTION. What determines whether alloantibody mediates acute or chronic allograft rejection remains unclear; here we examine the role of CD4 T cell help.METHODS. BALB/c hearts…2013 American Transplant Congress
Comparison of 20-Year Patient and Graft Survival for All Types of Solid Organ Transplants (Txs)
Purpose: To compare long-term patient survival and graft function (≥ 20 years) for all types of solid organ transplants (SOTs) and to define the state-of-the-art…
American Transplant Congress abstracts